Appili Therapeutics Inc. (TSX: APLI)
0.0400
0.00 (0.00%)
Aug 23, 2024, 3:53 PM EDT
Appili Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
Year Ending | TTM | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | Mar 31, 2020 | 2018 - 2016 |
---|---|---|---|---|---|---|---|
Cash & Equivalents | 0.3 | 0.09 | 2.47 | 6.66 | 11.06 | 10.51 | Upgrade
|
Short-Term Investments | - | - | - | - | 5.06 | 0.03 | Upgrade
|
Cash & Short-Term Investments | 0.3 | 0.09 | 2.47 | 6.66 | 16.12 | 10.54 | Upgrade
|
Cash Growth | -42.13% | -96.17% | -63.00% | -58.67% | 52.98% | 93.34% | Upgrade
|
Other Receivables | 1.79 | 1.17 | 0.42 | 1.39 | 1.69 | 0.31 | Upgrade
|
Receivables | 1.79 | 1.17 | 0.42 | 1.39 | 1.69 | 0.31 | Upgrade
|
Inventory | - | - | - | - | - | 0.04 | Upgrade
|
Prepaid Expenses | 0.12 | 0.19 | 0.23 | 0.18 | 0.45 | 0.22 | Upgrade
|
Total Current Assets | 2.21 | 1.46 | 3.12 | 8.24 | 18.26 | 11.11 | Upgrade
|
Property, Plant & Equipment | 0.03 | 0.03 | 0.01 | 0.04 | 0.05 | 0.06 | Upgrade
|
Total Assets | 2.23 | 1.49 | 3.13 | 8.28 | 18.32 | 11.17 | Upgrade
|
Accounts Payable | 4.51 | 4.11 | 2.75 | 6.38 | 4.45 | 1.26 | Upgrade
|
Accrued Expenses | 0.01 | 0.08 | 0.08 | 0.07 | 0.08 | 0.06 | Upgrade
|
Current Portion of Long-Term Debt | 9.2 | 7.31 | 0.11 | 0.1 | 0.09 | 0.05 | Upgrade
|
Current Income Taxes Payable | 0.04 | 0.05 | 0.04 | - | - | - | Upgrade
|
Total Current Liabilities | 13.77 | 11.54 | 2.98 | 6.67 | 4.62 | 1.38 | Upgrade
|
Long-Term Debt | 0.85 | 0.88 | 7.55 | 4.88 | 0.95 | 0.95 | Upgrade
|
Total Liabilities | 14.62 | 12.42 | 10.53 | 11.55 | 5.56 | 2.33 | Upgrade
|
Common Stock | 42.32 | 42.32 | 42.32 | 39.65 | 34.96 | 20.99 | Upgrade
|
Additional Paid-In Capital | 13.13 | 12.87 | 6.41 | 5.01 | 2.55 | 1.81 | Upgrade
|
Retained Earnings | - | -69.09 | -65.31 | -56.07 | -30.95 | -16.63 | Upgrade
|
Comprensive Income & Other | -67.84 | 2.98 | 9.18 | 8.13 | 6.19 | 2.67 | Upgrade
|
Shareholders' Equity | -12.39 | -10.92 | -7.4 | -3.27 | 12.75 | 8.85 | Upgrade
|
Total Liabilities & Equity | 2.23 | 1.49 | 3.13 | 8.28 | 18.32 | 11.17 | Upgrade
|
Total Debt | 10.05 | 8.18 | 7.67 | 4.98 | 1.03 | 1.01 | Upgrade
|
Net Cash (Debt) | -9.75 | -8.09 | -5.2 | 1.69 | 15.09 | 9.54 | Upgrade
|
Net Cash Growth | - | - | - | -88.83% | 58.28% | 120.06% | Upgrade
|
Net Cash Per Share | -0.08 | -0.07 | -0.05 | 0.03 | 0.26 | 0.28 | Upgrade
|
Filing Date Shares Outstanding | 121.27 | 121.27 | 121.27 | 121.27 | 62.83 | 61.6 | Upgrade
|
Total Common Shares Outstanding | 121.27 | 121.27 | 121.27 | 71.27 | 62.78 | 46.4 | Upgrade
|
Working Capital | -11.56 | -10.08 | 0.14 | 1.57 | 13.65 | 9.73 | Upgrade
|
Book Value Per Share | -0.10 | -0.09 | -0.06 | -0.05 | 0.20 | 0.19 | Upgrade
|
Tangible Book Value | -12.39 | -10.92 | -7.4 | -3.27 | 12.75 | 8.85 | Upgrade
|
Tangible Book Value Per Share | -0.10 | -0.09 | -0.06 | -0.05 | 0.20 | 0.19 | Upgrade
|
Machinery | - | 0.08 | 0.06 | 0.13 | 0.14 | 0.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.